Imperagen

Stub active Updated May 21, 2026

This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.

Location Manchester, United Kingdom
Founded 2021
Latest Stage Seed
Total Raised £5M+
Website https://imperagen.com/
Sector
biotech ai enzymes quantum deep-tech synthetic-biology

Founders

Andrew Currin Co-Founder
Tim Eyes Co-Founder
Andy Almond Co-Founder

About

Imperagen is a Manchester, UK-based biotech spun out of the Manchester Institute of Biotechnology in 2021 by Andrew Currin, Tim Eyes, and Andy Almond 1. The company develops enzyme engineering technology that combines quantum physics-based simulation with AI models to replace traditional trial-and-error lab processes with computational prediction of enzyme variants 1. The £5M (~$6.7M) Seed announced May 20, 2026 was led by PXN Ventures with participation from IQ Capital and Northern Gritstone 1.

Funding History

Date Round Amount Lead Co-investors
2026-05-20 Seed £5M PXN Ventures IQ Capital, Northern Gritstone 1

What Investors Say

No independently sourced investor quotes found at this time.

What Founders Say

No independently sourced founder quotes found at this time.

Sources

  1. TechCrunch, “Imperagen raises £5 million to redefine enzyme engineering,” May 20, 2026. Accessed May 2026. https://techcrunch.com/2026/05/20/imperagen-raises-5-million-to-redefine-enzyme-engineering/↩↩↩↩